Menu

20/20 Biolabs, Inc. AIDX

Full chart Compare
Set alert

Price alert · AIDX

All alert types
0.20 USD +0.01 (+4.98%)

Nov 6, 2026, 3:58 PM EST

0.1855 Day range 0.1981
0.18 52-week range 50.00
YTD
-99.18%
1 year
-99.18%

Revenue & Expenses

Revenue → Gross Profit: $604.54KGross Profit → Expenses: $604.54KRevenue → Cost of Revenue: $1.44MExpenses → Selling, General & Admin: $3.34MExpenses → Research & Development: $592.57KExpenses → Interest Expense: $156.21KExpenses → Other Expenses: $251.74KNet Loss → Expenses: $3.74MGross Profit$604.54KNet Loss$3.74MCost of Revenue$1.44MExpenses$4.34MSelling, General & Admin$3.34MResearch & Development$592.57KInterest Expense$156.21KOther Expenses$251.74KRevenue$2.05M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

AIDX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
2.05M1.75M1.42M
2.05M1.75M1.42M
1.44M1.39M1.32M
604.54K360.31K109.14K
3.94M6.02M6.47M
592.57K1.26M1.41M
3.34M4.76M5.06M
-3.33M-5.66M-6.36M
156.21K12.65K27.91K
-3.74M-5.55M-6.39M
-3.74M-5.55M-6.39M
-3.74M-5.55M-6.39M
-3.74M-5.55M-6.39M
-0.76-1.16-1.34
-0.76-1.16-1.34
-0.76-1.16-1.34
-3.58M-5.54M-6.36M
-3.58M-5.54M-6.36M
4.93M4.80M4.77M
4.93M4.80M4.77M